PP01.11 Furmonertinib is an Oral, Irreversible, Highly Brain-Penetrant Pan-EGFR Inhibitor with Activity Against Classical and Atypical EGFR Mutations

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

18

Issue :

3, Number 3 Supplement 1

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs62101527

Full Text :

https://doi.org/10.1016/j.jtho.2022.09.037